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ABSTRACT Equinatoxin II is a pore-forming protein of the actinoporin family. After membrane binding, it inserts its N-terminal
a-helix and forms a protein/lipid pore. Equinatoxin II activity depends on the presence of sphingomyelin in the target membrane;
however, the role of this speciﬁcity is unknown. On the other hand, sphingomyelin is considered an essential ingredient of lipid
rafts and promotes liquid-ordered/liquid-disordered phase separation in model membranes that mimic raft composition. Here,
we used giant unilamellar vesicles to simultaneously investigate the effect of sphingomyelin and phase separation on the
membrane binding and permeabilizing activity of Equinatoxin II. Our results show that Equinatoxin II binds preferentially to the
liquid-ordered phase over the liquid-disordered one and that it tends to concentrate at domain interfaces. In addition,
sphingomyelin strongly enhances membrane binding of the toxin but is not sufﬁcient for membrane permeabilization. Under the
same experimental conditions, Equinatoxin II formed pores in giant unilamellar vesicles containing sphingomyelin only when
liquid-ordered and -disordered phases coexisted. Our observations demonstrate the importance of phase boundaries for
Equinatoxin II activity and suggest a double role of sphingomyelin as a speciﬁc receptor for the toxin and as a promoter of the
membrane organization necessary for Equinatoxin II action.
INTRODUCTION
Pore-forming toxins (PFTs) are a group of toxic molecules
that exert their action by increasing the permeability of their
target membranes. As a consequence, ion gradients are dis-
rupted, which provokes osmotic swelling and cell death (1).
An interesting trait common to all PFTs is that they present
two stable structures: they are synthesized as water-soluble
monomers, and they insert into cell membranes to exert
their action (2). Then, PFTs follow a variety of mechanisms
to induce the formation ofmembrane pores (3). Some of them,
like bacterial cytolysins and the staphylococcal a-toxin,
form b-barrel channels (4,5). Others induce pores by in-
sertion of a-helices: they organize into pure protein a-helix
bundles, such as the antimicrobial peptide alamethicin, or
form mixed lipid/protein structures known as toroidal pores
(as in the case of actinoporins, colicins, and magainin or
melittin) (6). Toroidal pores are unstable and have not yet
been visualized. As a consequence, little structural infor-
mation is available (7).
Equinatoxin II (EqtII) belongs to the family of actino-
porins, eukaryotic PFTs exclusively found in sea anemones,
whose activity depends on the presence of sphingomyelin
(SM) in the target membrane (8). It efficiently lyses several
cell types and shows permeabilizing activity in model
membranes. The structure of the water-soluble form of EqtII
has been determined (9,10). It contains 179 amino acids
(19.8 kDa) that arrange into a hydrophobic b-sandwich core
surrounded by two a-helices on both sides. The first 30
N-terminal residues contain an a-helix that undergoes con-
formational changes during membrane insertion and pore
formation (11). The flexibility of this a-helix is necessary for
EqtII activity (12).
Some aspects of the mechanism of action of EqtII at
the molecular level have been unveiled during the past few
years. It includes an initial step of membrane binding, in
which a cluster of exposed aromatic residues is involved (12–14).
Then, the N-terminal helix dissociates from the b-sandwich
core, inserts into the lipid-water interface, and adopts an
orientation parallel to the membrane plane (3,11). Subse-
quently, EqtII monomers oligomerize and the N-terminal helix
reorients and crosses the bilayer to form the pore (11,15).
Several studies suggest that the EqtII pore is formed by 3–4
monomers that arrange into a toroidal structure lined by
N-terminal a-helices and lipids (16,17).
The role of SM in target membrane specificity is unknown.
It is essential for irreversible binding of EqtII and pore for-
mation, but it is not sufficient to provoke the dissociation of
the N-terminal helix from the b-sandwich in the presence of
phosphatidylcholine micelles and bicelles (18). On the other
hand, SM is a substantial ingredient of lipid rafts, which are
supposedly associated to the coexistence of liquid-disordered
(Ld) and SM-enriched liquid-ordered (Lo) lipid phases (19).
In this context, phase coexistence in SM-containing mem-
branes has been suggested to favor membrane insertion of
EqtII into the lipid packing defects at the interface (20).
During the past few years, giant unilamellar vesicles
(GUVs) have been proven to be valuable models for the study
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of processes at lipid membranes. With diameters varying
from a few to a hundred microns, GUVs have sizes compa-
rable to eukaryotic cells and are well distinguished by optical
microscopy. In addition to studies of membrane elasticity and
shape change (21,22), GUVs have been especially useful for
the investigation of phase-separating membranes and lipid
domains (23–25). In GUVs with raft-like composition, mac-
roscopic domains corresponding to Lo, enriched in SM, and
Ld phases can be clearly distinguished thanks to heteroge-
neous partitioning of fluorescent markers (25,26). GUVs have
also been used to study membrane permeabilization (27,28)
and the effect of EqtII pores on the transport of sucrose and
glucose molecules (29). The main advantage of using GUVs
versus the traditional methods based in small and large uni-
lamellar vesicles (LUVs) is that optical measurements can be
performed at the single-vesicle and even single-molecule
level while tracking membrane integrity. This provides novel
information about the mechanism of pore formation.
In this work, we used GUVs to simultaneously investigate
the role of SM and lipid phase coexistence in the membrane
binding and permeabilizing activity of EqtII. Our results
show that EqtII binds preferentially to the SM-enriched Lo
phase over the Ld phase. Interestingly, it concentrates at the
domain interface. Although the presence of SM strongly
promoted membrane binding, SM in a single-phase mem-
brane was not sufficient for membrane permeabilization. At
the same protein concentration, EqtII was able to permeabilize
SM-containing GUVs only when Ld and Lo phases coexisted.
Our observations demonstrate the importance of the phase
interface for EqtII activity and suggest that SM has a pivotal
role in acting as a specific receptor for EqtII while promoting
the membrane organization necessary for EqtII action.
MATERIALS AND METHODS
Chemicals
1,2-Dioleoyl-sn-glycero-3-phosphocholine (dioleoyl-phosphatidylcholine;
DOPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), N-stearoyl-
D-erythrosphingosylphosphorylcholine (stearoyl SM), and cholesterol were
purchased from Avanti Polar Lipids (Alabaster, AL). 1,19-Dioctadecyl-
3,3,39,39-tetramethylindodicarbocyanine perchlorate (DiD) and 1,19-
dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate (DiI) were
from Invitrogen (Carlsbad, CA).
Protein puriﬁcation and labeling
Two single-cysteine mutants of EqtII, EqtII-V22C, and EqtII-L26C were
produced as inMalovrh et al. (11). The two purifiedmutants EquII-V22C and
EquIIL-26C were labeled with Alexa Fluor 488 C5 maleimide (Invitrogen)
according to the manufacturer’s instructions. The separation of the labeled
protein from the free dye was achieved by a 10DG gel filtration column from
Bio-Rad (Hercules, CA), and the labeling was checked by spectroscopy mea-
surements done with a Specord S 100 from Analytik Jena (Jena, Germany).
Preparation of giant unilamellar vesicles
GUVs were prepared by electroformation (30). With this approach, truly
unilamellar vesicles are produced with sizes varying from 10 mm to 100 mm.
The electroformation chamber consists of two glass slides coated with op-
tically transparent and electrically conductive indium tin oxide that are held
apart by a Teflon or rubber spacer. A total of 3 ml of the corresponding lipid
mixture (10 mg/ml) together with 0.1% DiD or DiI (31) in chloroform/
methanol 2:1 were deposited on the preheated indium tin oxide glasses, and
the solvent was evaporated at 65C. After adding a 300 mM sucrose solution
to the chamber, a voltage of 1.4 V at 10 Hz was applied overnight. The
electroformed vesicles were then carefully pipetted out of the electro-
formation chamber and sedimented in 800 ml phosphate buffer saline (PBS;
137 mMNaC, 10mM phosphate, 2.7 mMKCl, pH 7.4). After a fewminutes,
either 150 ml were pipetted out from the bottom of the tube and distributed
into the four compartments of the observation chamber (Invitrogen) or 200ml
from several GUV-containing tubes were combined and gently mixed, and
then an eight-well observation chamber was filled with 100 ml per well. All
preparation steps were done at 65C to avoid lipid demixing. During cool-
down to room temperature in the observation chambers, phase separation
into Lo and Ld phases occurs, with DiD and DiI almost exclusively distrib-
uting into the Ld phase.
Confocal microscopy
Images were obtained at room temperature by confocal fluorescence mi-
croscopy, performed on a commercial ConfoCor3 from Zeiss (Jena,
Germany) with a laser scanning microscopy module. The excitation light of
an Ar ion laser at 488 nm and of a helium-neon laser at 633 nm was reflected
by a dichroic mirror (HFT 488/633) and focused through a Zeiss C-Apo-
chromat 403, NA ¼ 1.2 water immersion objective onto the sample. The
fluorescence emission was recollected by the same objective and split by
another dichroic mirror (NFT 545) into two channels. Detection of the fluo-
rescence emission, after passing a 505–530 nm band-pass filter in the first
channel and a 650 nm long-pass filter in the second channel, was obtained
with two avalanche photodiodes.
Measurements of membrane binding
and permeabilization
Protein binding distributions were calculated by sampling over several
vesicle preparations. We quantified the fluorescence intensities of EqtII-
Al488 in the Lo and the Ld phases within a single vesicle and calculated the
intensity ratio ILoF =I
Ld
F half an hour after the addition of ;10 mg/ml (final
concentration) of one of the labeled EqtII mutants.
Pore activity measurements were done by adding a PBS solution con-
taining Alexa Fluor 488 (molecular mass 720 Da) as a marker as well as the
unlabeled EqtII to the vesicles and gently mixing the sample to achieve a
largely homogeneous distribution of vesicles, marker, and protein. After 45
min the number of GUVs into which the marker had penetrated was counted
versus the total number of vesicles in several regions of the sample. Up to 600
vesicles were evaluated per data point.
The degree of filling was determined by taking a sample image every 30 s
and comparing the intensity of the fluorescence marker within a vesicle with
the intensity just outside the GUV.
RESULTS
EqtII prefers the Lo over the Ld phase and
concentrates at the domain interface
EqtII binding and insertion into lipid membranes is affected
by the presence of SM (17), which is related to cellular lipid
rafts (19). Model membranes that contain SM, DOPC, and
cholesterol in a raft-like composition show the coexistence of
Ld and Lo phases (26,31,33,34). The Lo phase is enriched in
SM and is characterized by conformational order in the lipid
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acyl chains, whereas their lateral and rotational lipid mobility
is more similar to the Ld phase than to the gel phase (19).
To investigate the effect of membrane phase and compo-
sition on the binding affinity of EqtII, we performed binding
experiments in GUVs with different lipid mixtures. As ex-
plained in Materials and Methods, two EqtII mutants were
labeled to homogeneity and used for experiments. The mu-
tations used were from the N-terminal region, which is not
close to the region of the molecule that interacts with the lipid
membrane (12,13,18). In our experiments, the two mutants
showed exactly the same behavior, both in binding and
permeabilization. When the mutant is not specified, the
general name EqtII-Al488 is used to denote results obtained
for both labeled mutants.
We added EqtII-Al488 to GUVs that contained SM and to
GUVs that did not contain SM, with only Ld or Lo phase, or
Ld-Lo phase coexistence. The membranes were labeled with
DiD or DiI, which partition preferentially to the Ld phase
(25). After 30 min incubation, we checked for membrane
binding by confocal microscopy. As observed in Fig. 1,
EqtII-Al488 binds preferentially to vesicles containing SM.
In Fig. 1, E–H, a control without SM (lipid composition
DOPC/cholesterol (1:1)) shows no membrane binding of the
toxin under these conditions. When EqtII-V22C-Al488 was
added to a mixture of SM-containing GUVs with only the Lo
(SM/cholesterol, 1:1) or Ld (SM/DOPC, 1:1) phase (25), the
toxin bound preferentially to the vesicles in the Lo phase (see
Fig. 1, A–D). Fig. 1, I–N, depicts the binding of Alexa-488-
labeled mutants of EqtII to GUVs containing SM and ex-
hibiting Ld-Lo phase coexistence (DOPC/SM/cholesterol,
1:1:1). The three-dimensional projections of representative
GUVs show that the toxin binds preferentially to the
SM-enriched Lo phase over the Ld phase. Interestingly,
intense dots of EqtII-L26C-Al488 localize at some of the
phase boundaries, indicating the tendency of the protein to
concentrate at the interface.
FIGURE 1 Effect of lipid composition
on membrane binding of EqtII-Al488.
EqtII-Al488 was added to GUVs
containing DiD or DiI, which are lipo-
philic dyes that label specifically the Ld
phase. Vesicles labeled with DiD are
depicted in red, DiI is depicted in yellow,
and the fluorescent mutants of EqtII are
depicted in green. (Top row) Mixture of
GUVs composed of DOPC/SM (1:1)
0.1% DiD (A) and SM/Chol (1:1) 0.1%
DiI (B) 30 min after addition of EqtII-
V22C-Al488 (C). Merge shown in D.
(Second row) Mixture of GUVs com-
posed ofDOPC/Chol (1:1) 0.1%DiD (E)
and SM/Chol (1:1) 0.1% DiI (F) after
addition of EqtII-V22C-Al488 (G).
Merge shown in H. Scale bars, 20 mm.
(Third and fourth rows) DOPC/SM/Chol
(1:1:1) 0.1%DiD (I and L), EqtII-V22C-
Al488 (J), and EqtII-L26C-Al488 (M),
merge in K and N. For clarity, the Lo / Ld
intensity ratios of EqtII mutants in the
third and fourth rows are 1.5 and 4,
respectively. Scale bar, 10 mm.
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Assuming that the fluorescence intensity in GUVs is pro-
portional to EqtII-Al488 concentration, we quantified the
phase binding preference of EqtII-Al488 by calculating the
partitioning of the protein between both Lo and Ld phases in a
large number of different vesicles. The results obtained are
represented in Fig. 2 and include data from both mutants. The
spread of the data is indicative of the heterogeneity of the
system. EqtII-Al488 bound more extensively to the Lo phase
in the majority of the vesicles (69%), ranging from a 1.5-fold
to a 10-fold preference for this phase. A minor number of
vesicles exhibited homogeneous distribution or higher con-
centration in the Ld phase.
EqtII pore-forming activity depends on the
presence of phase separation
To determine whether the differences observed in binding
affinity have an effect on the pore-forming activity of EqtII,
we carried out experiments of membrane permeabilization in
GUVs. GUVs of the desired lipid compositions were pre-
pared, and Alexa-488 together with unlabeled EqtII was
added to the external solution. Vesicle permeabilization
caused an increase in fluorescence intensity inside the GUVs,
indicative of filling with Alexa-488. Such a system allows
simultaneous verification of vesicle integrity and Ld-Lo phase
coexistence while measuring pore activity.
Fig. 3 shows the vesicles immediately after the addition of
Alexa-488 and EqtII to the external medium (Fig. 3, A–D )
and after 45 min of incubation at room temperature (Fig. 3,
E–H). In all cases vesicles retained their integrity upon toxin
treatment. The GUVs in Fig. 3, A and E, were made of
DOPC/cholesterol (1:1) and were not permeabilized after
incubation with EqtII. Under similar conditions, EqtII
showed pore-forming activity in vesicles composed of
DOPC/SM/cholesterol (1:1:1), which exhibit Ld-Lo phase
separation (Fig. 3, C andG). However, GUVs containing SM
but no phase coexistence (SM/cholesterol, 1:1) were not
permeabilized by EqtII (Fig. 3, B and F ), despite toxin
binding to the membrane (as shown in Fig. 1, E–H). As a
control, bovine serum albumin (BSA) was added to GUVs
made of DOPC/SM/cholesterol (1:1:1), and only rare vesicle
permeabilization was observed (Fig. 1, D and H).
These observations indicate that phase separation has a
strong effect on promoting EqtII pore-forming activity. To
check this possibility, we measured EqtII permeabilizing
activity in GUVs composed of DOPC/DPPC/cholesterol
(1:1:1), which do not contain SM but do exhibit a phase
coexistence. As summarized in Table 1, under the same
conditions, EqtII was able to permeabilize 67% of vesicles, in
comparison with 98% activity in DOPC/SM/cholesterol
(1:1:1). Interestingly, the addition of SM to only 5% (DOPC/
DPPC/cholesterol/SM, 1:1:1:0.16) recuperated the activity of
EqtII to 96%. Our results indicate that the coexistence of Ld
and Lo phases is enough to enhance the pore-forming activity
of EqtII and that the presence of SM has a synergistic effect
by increasing EqtII binding to the membrane.
Permeabilization of GUVs is a stochastic
and fast event
Bulk experiments of vesicle permeabilization show cooper-
ative behavior in the concentration-dependent activity of
many PFTs, including EqtII (17,35–38). In contrast to tra-
ditional assays of content release from LUVs (which provide
information about the average permeabilization from all the
LUVs in the suspension), permeabilization experiments in
GUVs provide information about events at the single vesicle
level (they analyze the fraction of the permeabilized vesicles
among all the examined ones). To check if the information
obtained from GUVs is comparable to content release ex-
periments in LUVs, we measured the pore activity of EqtII at
several protein concentrations. Fig. 4 shows the percentage of
vesicles permeabilized as a function of the toxin concentra-
tion. The activity curve obtained is similar to the results
obtained in bulk experiments (17). Under our experimental
conditions, 50% of vesicles were permeabilized at ;4.3 mg/
mL of EqtII.
In addition to average activity, experiments of GUV per-
meabilization allow us to investigate the filling kinetics of
single vesicles. Fig. 5 A shows the grade of vesicle filling as a
function of time for several individual vesicles. In general,
membrane permeabilization started at ;20 min after mixing
the GUVs with EqtII. After this lag time, the increase of
fluorescence intensity inside the vesicles started stochasti-
cally, and complete filling was rapidly achieved within times
varying from ;1–5 min.
From these data, we can calculate the volume flux JV
through the membrane. Assuming a constant fluorophore
FIGURE 2 Partition of EqtII-Al488 between the Ld and Lo phases.
Fluorescence intensity was measured 30 min after adding ;10 mg/mL of
any of the EqtII-Al488 mutants to GUVs of lipid composition DOPC/SM/
cholesterol (1:1:1), 0.1% DiD. The ratio of EqtII-Al488 in the Ld and Lo
phases was calculated for 72 vesicles and plotted as a normalized histogram.
Bin size, 0.5.
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concentration cext, set to 1 for simplicity, the fluorophore
concentration c(t) inside a GUV will change during the time
interval dt in this manner:
cðt1 dtÞ ¼ cðtÞ1 dNext/i  dNi/ext
Vi
; (1)
where dNext/i and dNi/ext are the fluorophores that cross
the membrane from the outside to the inside and vice versa,
respectively, and Vi is the vesicle volume, also assumed to be
constant. With c ¼ N/V. this leads to
cðt1 dtÞ ¼ cðtÞ1 1 cðtÞ
Vi
dV ¼ cðtÞ1 1 cðtÞ
Vi
JVAdt (2)
with A as the vesicle surface. Since the GUVs can be regarded
as spheres, A¼ 4pR2, and V¼ 4p/3R3, the above expression
can be written as the differential equation:
c9ðtÞ ¼ 3JV
R
ð1 cðtÞÞ: (3)
The starting condition c(0) ¼ c0 ¼ 0 yields the solution
cðtÞ ¼ 1 e
3JV
R
t
: (4)
Expressed as in Eq. 5, the slope of the curve directly shows
the volume flux JV:
R
3
lnð1 cðtÞÞ ¼ JVt: (5)
Table 2 shows the volume flux JV in the individual vesicles,
calculated from the slopes in Fig. 5 B according to Eq. 5. The
spread values obtained show the heterogeneity of the filling
process, which gives an average filling flux of 86 5mm/min.
DISCUSSION
Permeabilization of single vesicles
We used a similar approach to Yamazaki and co-workers for
membrane permeabilization studies in single GUVs (28,39).
Our results show that membrane permeabilization by EqtII in
single vesicles was comparable to bulk experiments when
averaged. But in addition, they allowed us to confirm vesicle
integrity during permeabilization and to simultaneously
measure the filling kinetics at the single vesicle level. We
observed that after addition of the toxin, a lag time of ;20
min was necessary for pore formation. A similar behavior
FIGURE 3 Effect of membrane phase
and composition on the permeabilizing
activity of EqtII. (A–C) The samples
immediately after adding 30 mg/mL of
EqtII-L26C (first column) or EqtII-
V22C (second and third columns), or
the same amount of BSA in the forth
column. (E–H) The same samples as
A–D after 45 min incubation at room
temperature. Lipid composition of GUVs:
(A and E) DOPC/cholesterol (1:1) 0.1%
DiI; (B and F) SM/cholesterol (1:1)
0.1% DiD; (C, D, G, and H) DOPC/
SM/cholesterol (1:1:1) 0.1% DiD. DiD
and DiI specifically label the Ld phase
and for clarity are depicted in red. The
surrounding solution was colored with
Alexa-488 (green) at 300 nM. The scale
bars correspond to 20 mm.
TABLE 1 Effect of SM and phase separation on the
permeabilizing activity of EqtII-Al488
Lipid composition
Percent of
filled GUVs
DOPC/SM/cholesterol (1:1:1) 98 6 1
DOPC/DPPC/cholesterol (1:1:1) 67 6 4
DOPC/DPPC/cholesterol/SM (1:1:1:0.16) 96 6 2
In all cases, a total number of at least 500 vesicles was counted. The error
bars correspond to a counting error of 10%.
FIGURE 4 Permeabilization activity of EqtII in GUVs as a function of
toxin concentration. Pore activity was calculated as the percentage of filled
vesicles 45 min after addition of EqtII-V22C. Between 200 and 300 vesicles
were considered for each data point. The error bars correspond to a counting
error of 10%. Vesicles are composed of DOPC/SM/cholesterol (1:1:1) 0.1%
DiD.
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was obtained in bulk experiments of vesicle permeabilization
and hemolysis (17). Since binding to lipid membranes occurs
in seconds (12), processes like oligomerization, conforma-
tional changes, and insertion of the N-terminus a-helix
probably contribute to the lag time. This is also in agreement
with the two-state model of pore formation by Huang and
colleagues (40). According to this model, toxin binding to the
outer leaflet would introduce additional area, so that a stress
in the membrane, or membrane tension, would be created.
After enough toxin molecules have bound, the membrane
tension generated would destabilize the bilayer and provoke
pore opening. Though, to our knowledge, no membrane-
thinning effect has been measured for EqtII to date, insertion
of the N-terminal a-helix of EqtII, which is related to pore
formation (3,15), has been shown to increase the lateral
pressure in monolayers (12).
The variations in the lag time for pore formation measured
in the individual vesicles are probably related to the hetero-
geneities in the system and the stochastic nature of pore
opening (28). Once pore opening took place, vesicle filling
was fast and complete within a few minutes. This is in the
same time range observed for other molecules, like magainin
or epigallocatechin gallate (28,39). We derived an equation
to calculate the rate of vesicle filling. The differences ob-
served in the estimated filling fluxes may arise from a dif-
ferent number of pores per vesicle, from pores with different
sizes, and/or from a different Laplace pressure in the indi-
vidual vesicles (41).
Role of SM in EqtII activity
The presence of SM enhances the binding of EqtII to the
membrane (20). Although the molecular basis for this lipid
specificity is unknown, SM is necessary for the irreversible
binding of the toxin to the membrane, which is followed by
insertion and pore formation (42). However, as shown by
NMR studies, SM is not sufficient to trigger the conforma-
tional change that inserts the N-terminal a-helix responsible
for pore opening, at least in micelle and bicelle model mem-
brane systems (18). Though EqtII also interacts with lipid
membranes in the absence of SM, our observations in GUVs
clearly evidence a preference for the binding to SM-containing
vesicles and highlight the role of SM as a receptor for EqtII.
SM is a derivative of sphingosine, with a fatty acid at-
tached to the two-amino group through amide bonding. In
mammals, this fatty acid usually has a long saturated acyl
chain and, together with the sphingosine acyl chain, forms
the hydrophobic part of the sphingolipids (19). Such a struc-
ture constitutes an excellent interaction partner for choles-
terol, via both hydrogen bonding between the hydroxyl group
of cholesterol and the amide group in the sphingosine, and
hydrophobic interactions of the rigid cholesterol rings with
the SM acyl chains (19). As a consequence of this
differential interaction, Lo phases enriched in SM and
cholesterol coexist with Ld phases in model membranes
containing phosphatidylcholine, cholesterol, and SM over a
large range of compositions, which include those mimicking
the outer leaflet of the plasma membrane (24,26,31,34,44).
Indeed, a similar situation is believed to occur in the plasma
membrane of mammalian cells, where the preferential inter-
action of sphingolipids with cholesterol gives rise to small
domains of transient nature known as lipid rafts (19). This
notion is supported by experiments with dyes sensitive to
FIGURE 5 Kinetics of a single vesicle filling. (A) Filling grade of several
individual vesicles as a function of time. Experimental conditions corre-
spond to 10 mg/mL of EqtII-L26C added to sample GUVs composed of
DOPC/SM/cholesterol (1:1:1) 0.1% DiD. (B) Dye flux into the same
individual vesicles, expressed according to Eq. 5.
TABLE 2 Dye ﬂux J into single GUVs permeabilized
by EqtII-Al488
Vesicle Radius (mm) J (mm/min)
1 44 3.0
2 27 6.6
3 32 4.9
4 21 12.0
5 32 15.3
J values were calculated from the slopes in Fig. 5 B according to Eq. 5.
696 Scho¨n et al.
Biophysical Journal 95(2) 691–698
lipid environments that support the existence of Lo-like do-
mains in the outer membrane of mammalian cells (45–47).
In our experiments with phase-segregated GUVs, EqtII
bound preferentially to the Lo phase. This phase distribution
is probably due to the enrichment of SM in the Lo phase,
which acts as a specific receptor. But interestingly, a consid-
erable amount of toxin concentrated at the phase boundaries.
As shown by atomic force microscopy and crystallography
studies, in model membranes the Lo phase is thicker than the
Ld phase due to the higher conformational order of the acyl
tails (33,48–52). To avoid the exposure of hydrophobic
chains to the aqueous solvent, the lipids bend elastically at the
domain interface, causing curvature stress, which has an
energetic cost per length unit or line tension (26). As a con-
sequence, there is a higher concentration of packing defects at
the phase boundaries, which likely favor the binding of EqtII
because of its amphipathic nature. A similar behavior has
been observed for other proteins, including a peptide derived
from helix 5 of Bax, PLA-2, and N-Ras (33,53,54). This may
be a mechanism to increase the local concentration of EqtII
and hence to reach the threshold for pore formation (40).
Indeed, our experiments of membrane permeabilization in
GUVs showed that at a certain toxin concentration, SM was
not sufficient to promote pore opening, but phase coexistence
was necessary. Interestingly, EqtII showed considerable
permeabilizing activity in phase-separated GUVs without
SM. The addition of a small amount of SM to phase-sepa-
rated membranes, which would enhance EqtII binding, re-
stored activity to almost 100% permeabilization.
Taken together, these observations highlight the dual role
of SM in promoting EqtII activity. On one hand, it acts as a
specific receptor for the toxin and promotes irreversible
membrane binding (20,42). On the other hand, SM induces
Ld-Lo phase separation in the presence of cholesterol (19),
thus collaborating in the creation of lipid interfaces that in-
crease the local concentration of EqtII and enhance pore
opening. Interestingly, a comparable situation occurs in the
case of the cholesterol-dependent cytolysins, an unrelated
group of toxins that permeabilize membranes through the
formation of b-barrel pores. Likewise, cholesterol is implied
both in the binding process, acting as a receptor, and in the
mechanism of pore formation (55). It is therefore tempting to
hypothesize that SM- and cholesterol-dependent PFTs have
evolved to use these features of the outer plasma membrane
to optimize their activity. Concretely, they would do so by
using lipids within lipid rafts as receptors and phase separa-
tion as a mechanism to increase local concentration. In fact,
given the strong effect of phase separation on EqtII pore
formation in model membranes, one may further speculate
that its lytic activity in mammalian cells represents indirect
evidence of phase separation in membranes.
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